A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
compliance with study procedures All Asthma Cohorts
physician diagnosed Asthma greater or equal to 3 months prior to screening visit
You may not be if
history of alcohol or drug abuse within the past year
pregnant at time of an assessment
has an altered mental status at the time of informed consent
receipt marketed or investigational biologic(s) within 3 months or 5 half-lives prior to visit 1, whichever is longer
history or current upper or lower respiratory infection or symptoms within 2 weeks of baseline assessments
terminal diseases and/or organ failure or participants otherwise considered not appropriate for the study participation
Receipt LTRAs or 5-lipoxygenase (5-LO) inhibitors (eg zileuton and montelukast) within 1 month or 5 half-lives prior to baseline, whichever is longer.
Clareo Health | A Translational Study to Describe Clinical Characteristics, Biomarkers and to Identify Phenotypes and Endotypes Associated With Differential Outcomes in Chinese Population
